These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21425135)

  • 1. Prognosis and pathology of screen-detected carcinomas: how different are they?
    Nagtegaal ID; Allgood PC; Duffy SW; Kearins O; Sullivan EO; Tappenden N; Wallis M; Lawrence G
    Cancer; 2011 Apr; 117(7):1360-8. PubMed ID: 21425135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer.
    Sweeney KJ; Kell MR; Aziz NA; Prunty N; Holloway P; Kennedy M; Flanagan F; Kerin MJ
    Ir Med J; 2007 Sep; 100(8):550-2. PubMed ID: 17955686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen-detected breast cancers have a lower mitotic activity index.
    Groenendijk RP; Bult P; Tewarie L; Peer PG; van der Sluis RF; Ruers TJ; Wobbes T
    Br J Cancer; 2000 Jan; 82(2):381-4. PubMed ID: 10646892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval breast cancers: prognostic features and survival by subtype and time since screening.
    Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
    J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
    Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
    J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study.
    Cowan WK; Kelly P; Sawan A; Cunliffe WJ; Henry L; Higgs MJ; Lunt LG; Young JR; Horne CH; Angus B
    J Pathol; 1997 May; 182(1):29-35. PubMed ID: 9227339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of screen-detected breast cancers: results of a population based study.
    Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
    BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.
    Garvican L; Littlejohns P
    Public Health; 1998 Jan; 112(1):15-20. PubMed ID: 9490883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
    Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
    Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology characteristics that optimize outcome prediction of a breast screening trial.
    Anderson TJ; Alexander FE; Lamb J; Smith A; Forrest AP
    Br J Cancer; 2000 Aug; 83(4):487-92. PubMed ID: 10945496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screen-detected breast carcinomas--do they differ from those diagnosed outside screening programs?
    Toikkanen S; Dean PB; Joensuu H
    Pathol Annu; 1994; 29 Pt 1():261-79. PubMed ID: 8127625
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic importance of palpability as a feature of screen-detected breast cancers.
    Gill G; Luke C; Roder D
    J Med Screen; 2006; 13(2):98-101. PubMed ID: 16792834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Better prognosis and favorable tumor stages in patients with invasive breast mammary carcinoma after introduction of the mass screening of breast cancer in Tilburg, the Netherlands].
    Groenendijk RP; Bult P; Wobbes T
    Ned Tijdschr Geneeskd; 2004 May; 148(19):961; author reply 961-2. PubMed ID: 15160564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.